Usage: bictiravir (BIC) is a second-generation integrase chain transfer inhibitor (insi). It has been approved to be used in combination with ntriptabine and tenofovir alafenamide fixed dose for HIV treatment. Bictiravir has effective anti-virus activity against wild-type virus and first-generation drug-resistant strains in vitro.
Properties
Summary
Bictetiravir (BIC), a second-generation integrase chain transfer inhibitor (insi), has been approved to be used in combination with a fixed dose of enrotabine and tenofovir alafenam chemical bookide for HIV treatment. Bictetiravir has effective antiviral activity against wild-type viruses and first-generation drug-resistant strains in vitro.
CRO
